R&D strategy

R&D strategy Agency Consulting firm Experts Specialists Consultancy

Develop your pipeline strategy and R&D portfolio management

Alcimed helps its clients build successful research and development strategies, meaning the ability to fuel, create and maintain a strong pipeline of innovative products or services and to adopt effective R&D portfolio management, while aligning organizations cross-functionally.

    Tell us about your uncharted territory

    You have a project and want to discuss it with our explorers, write us!

    One of our explorers will contact you shortly.


    They trust us

    Logo_carre_APHP
    Logo_carre_Bayer
    Logo_carre_Boehringer_Ingelheim
    Logo_carre_Grand_Lyon
    Logo_carre_J&J
    Logo_carre_Loreal
    Logo_carre_Mars
    Logo_carre_Michelin
    Logo_carre_Moderna
    Logo_carre_Nesle
    Logo_carre_reseau_SATT
    Logo_carre_Roche
    Logo_carre_Saint_Gobin
    Logo_carre_Sanofi
    Logo_carre_Solvay
    Logo_carre_Suez
    Logo_carre_Thales

    The challenges related to R&D strategy

    As R&D strategies are crucial for businesses’ growth, they should be developed with input from across all the key company stakeholders. Any new product is always in relation to ever-changing technical and market dynamics, so companies need to keep a finger on the pulse of each sector they play in (or will play in) and be able to anticipate the key trends to correctly time the decision to push development forward or stop.

    The key challenges in R&D strategy are:

      Tell us about your uncharted territory

      You have a project and want to discuss it with our explorers, write us!

      One of our explorers will contact you shortly.


      How we support you in your R&D srategy and R&D portfolio management

      At Alcimed, we help our clients in their pipeline and portfolio strategies at all stages of their research and development stages:

      • Across the scientific and industrial research ecosystem: R&D departments of innovative industry leaders, academic labs and KOLs, spin-off start-ups, biotechs/medtechs
      • Of various sizes: major pharmaceutical, biotech and medtech manufacturers, as well as smaller innovative companies
      • With functions across R&D: pipeline & portfolio strategies, New Product Strategy, Translational research, External Innovation, etc.
      • At all stages of R&D: In pre-discovery, discovery, preclinical and clinical development stages up to a new product launch
      • On their in-line assets and new products pipeline (drugs, medtech) and R&D supporting technologies and models (e.g. biomarkers, assays, high-throughput screening, in silico modeling, etc.)

      We leverage Alcimed’s 30-year presence in the field and our team of scientific and medical background and training to continuously observe, explore, interact with key research stakeholders in the healthcare innovation space and analyze the trends in the scientific field and industrial applications, to guide our clients in the organization and advancement of their R&D pipeline.

      Key topics we have covered include: scientific state-of-the-art to identify new research areas (metabolic pathways, mechanism of actions, etc.) and identify trending drug modalities and new drug discovery platform to create; identifying and evaluating new assays and biomarker candidates to develop and include to clinical development programs; assessing the competitive landscape in the research and clinical development space; early opportunity evaluation and go/no go assessment for platform or program development; organization of the go/no-go decision-making process at every steps of the research and development program… among many other topics!

      Examples of recent R&D strategies carried out for our clients

      • Assessing the translatability of a novel technology platform

        A client wanted to understand what the potential lead indications would be best suited to prove the therapeutic value of its immune regulatory platform.

        Alcimed conducted an analysis of the state-of-the-science, helped prioritize potential therapeutic cellular targets to place into R&D to regulate complement fixation both when it creates or prevents disease, and recommended potential academic and private research labs to collaborate with as part of the client’s R&D strategy and capability requirements roadmap.

      • Diagnosis & vision for a new pipeline assessment process

        An innovative biotech companies asked for our help to strengthen its pipeline evaluation process, to be more robust, systematic and reproductible across its current and future drug development programs, as well as more specific to its strategic vision, culture, and organization.

        After aligning the executive team around a common vision of the process need, Alcimed brought inspirational benchmarks and led the collaborative building of a new process of stage-gated evaluation and decision-making of its existing and future pipeline.

      • Building a business case with early opportunity evaluation for new diseases

        The R&D portfolio strategy team of a pharmaceutical company needed help to lead its choice of the next diseases to invest research & development for, based on a first high-level landscaping of five markets of interest (high medical unmet need).

        Alcimed reconstructed such landscapes by analyzing critical industry parameters (epidemiology, unmet need, competition now and in development, etc.) and in the end gave a go/no-go, prioritization and “how to” recommendation.

      • Strategy to improve the R&D performance of an industrial player

        We helped a leading company in the space industry improve its R&D strategy. Our client’s main challenge was to build a reference framework that would enable it to assess the relevance of the projects in its R&D portfolio. It would allow our client to objectively decide which project to pursue or discontinue, and ultimately optimize performance.

        We carried out an initial internal phase aimed at understanding the existing R&D process, its pain points and the key criteria to be considered in order to optimize project analysis. We then benchmarked with comparable players (very long product cycles, substantial R&D investment, ….) to understand best practices and pitfalls to avoid in this area.

        All the elements gathered enabled us to build a customized reference framework (criteria, an evaluation scale for each criterion, metrics, etc.) integrating the dimensions of strategic fit, business elements, degree of innovation, human aspects, etc.

      You have a project?

        Tell us about your uncharted territory

        You have a project and want to discuss it with our explorers, write us!

        One of our explorers will contact you shortly.